TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup on Oct. 11, 2026, of eight comments from clinicians and health leaders responding to recent health news. Topics included FDA warnings about unapproved herpes treatments sold on Amazon, the measles response, infection prevention and early research into treatments for serious conditions.
MedPage Today published a weekly roundup on Oct. 11 featuring comments from clinicians and health leaders on recent medical and public health developments, from unapproved herpes treatments sold on Amazon to measles response and emerging research. The collection presents the speakers’ reactions and views; it is not a single new study or policy announcement.
The roundup’s lead quote came from Jeffrey Klausner, a physician and public health specialist with Herpes Cure Advocacy. Responding to news that the Food and Drug Administration warned Amazon over the sale of unapproved herpes treatments, Klausner said: “The public should not be subject to these quack medicines.” The item does not provide details of the warning, identify the products, or give Amazon’s response.
Other remarks addressed public health and representation in government. Jeanne Marrazzo, former director of the National Institute of Allergy and Infectious Diseases, called the federal response to the U.S. measles outbreak “extremely underwhelming and frankly shameful.” The roundup also cited Jennifer Mensik Kennedy, president of the American Nurses Association, who noted that 18 nurses were running for Congress in the election and said, “We should have more nurses.”
Several quotes concerned clinical care and research. Sanjay Saint discussed hospitals’ efforts to prevent catheter-associated urinary tract infections; Brian Jenssen said clinicians should ask about vaping exposure as well as smoking in the homes of children with asthma. Other comments addressed a reported spike in a rare fungal infection, a small study of radiosurgical treatment for treatment-resistant depression and suicidal ideation, and research into optogenetic therapy for advanced retinitis pigmentosa.
Concerns Across Health Care
The collection captures how clinicians and health leaders are framing issues that can affect patient safety, public health and access to care. Klausner’s comment draws attention to the risks of consumers encountering unapproved treatments online, while Marrazzo’s criticism reflects concern about the government response to measles. These are attributed opinions, not independent findings established by the roundup.
The other topics point to different kinds of decisions: hospitals’ infection-prevention practices, questions clinicians ask about children’s exposure to vaping, and how cautiously to interpret small or early studies. For readers, the distinction matters: a forceful quote can signal professional concern, but it does not by itself establish a treatment’s effectiveness, the scale of a health threat, or the adequacy of a policy response.
Eight Voices, Varied Developments
MedPage Today described the piece as a collection of quotable remarks heard by its reporters and published it as a weekly roundup. The eight comments refer to separate news items rather than one shared event. Alongside the FDA warning and measles response, the source mentions hospital practices aimed at preventing catheter-associated urinary tract infections and a study concerning children with asthma exposed to vaping and combustible tobacco.
The research-related remarks cover very different stages and conditions. Joshua Lieberman commented on a spike in a rare, potentially deadly fungal infection occurring beyond typical high-risk groups with profound immunosuppression. Mohamed Khattab discussed a small study of radiosurgical capsulotomy for treatment-resistant depression and suicidal ideation. Richard Rosen addressed a study of optogenetic therapy intended to induce light sensitivity in retinal cells among people with advanced retinitis pigmentosa. The roundup supplies no study data or detailed methods for these items.
““The public should not be subject to these quack medicines.””
— Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy
Details Behind the Quotes
The roundup does not provide the FDA warning itself, the names of the herpes products, Amazon’s response, or the agency’s requested actions. It also gives no further detail about the government’s measles response or Marrazzo’s basis for judging it. Those claims and assessments cannot be independently evaluated from the quote collection alone.
For the research items, the source does not report sample sizes beyond describing the radiosurgical capsulotomy study as small, nor does it provide methods, outcome measures, follow-up periods or full results. The scale and causes of the fungal infection spike are also not stated. The roundup’s brief descriptions do not establish that any experimental treatment is proven, widely available or suitable for patients.
Follow the Underlying Reports
The next developments depend on the separate stories behind the quotes. Readers seeking details about the online products can look for the FDA’s warning and any response from Amazon. Further information on measles policy and the other public health concerns would need to come from official updates and the underlying reporting.
For the studies, the relevant next steps are publication of full results, scrutiny of research methods and, where appropriate, further clinical testing. The weekly roundup itself announces no new regulatory action, election result or research milestone beyond the developments it summarizes.
Key Questions
What did MedPage Today publish?
It published a weekly collection of eight quotes from clinicians and health leaders commenting on separate medical and public health stories.
What prompted Klausner’s criticism of herpes treatments?
The roundup says Klausner was responding to news that the FDA warned Amazon for selling unapproved herpes treatments. It does not identify the products or include the warning’s details.
Did the roundup report a new measles policy?
No. It quoted former NIAID director Jeanne Marrazzo criticizing the federal response to the U.S. measles outbreak, but did not announce a new policy or provide further details about the response.
Do the treatment studies show that the approaches work?
The quote collection does not provide enough study information to determine that. It describes the radiosurgical capsulotomy findings as coming from a small study and gives no full results or methods for either that research or the optogenetic therapy study.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
